A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month Result.

Kikushima, Wataru; Sakurada, Yoichi; Fukuda, Yoshiko; Matsubara, Mio; Kotoda, Yumi; Sugiyama, Atsushi; Kashiwagi, Kenji

Kikushima, Wataru; Sakurada, Yoichi; Fukuda, Yoshiko; Matsubara, Mio; Kotoda, Yumi; Sugiyama, Atsushi; Kashiwagi, Kenji.

Afiliação

Kikushima W; Department of Ophthalmology, Faculty of Medicine, University of Yamanashi, Yamanashi 409-3898, Japan.
Sakurada Y; Department of Ophthalmology, Faculty of Medicine, University of Yamanashi, Yamanashi 409-3898, Japan.
Fukuda Y; Department of Ophthalmology, Faculty of Medicine, University of Yamanashi, Yamanashi 409-3898, Japan.
Matsubara M; Department of Ophthalmology, Faculty of Medicine, University of Yamanashi, Yamanashi 409-3898, Japan.
Kotoda Y; Department of Ophthalmology, Faculty of Medicine, University of Yamanashi, Yamanashi 409-3898, Japan.
Sugiyama A; Department of Ophthalmology, Faculty of Medicine, University of Yamanashi, Yamanashi 409-3898, Japan.
Kashiwagi K; Department of Ophthalmology, Faculty of Medicine, University of Yamanashi, Yamanashi 409-3898, Japan.

Pharmaceuticals (Basel) ; 16(4)2023 Apr 07.

Article em En | MEDLINE | ID: mdl-37111318

Palavras-chave

age-related macular degeneration; intravitreal brolucizumab injection; polypoidal choroidal vasculopathy; switching; treat-and-extend

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google